Pfizer starts a study to test its oral antiviral drug against COVID19 among those who have been exposed to the coronavirus . In the trial, PF-07321332, designed to block the ability of the virus to multiply, will be administered along with ritonavir.
Clinical trials are still under way to determine if ivermectin has any benefits against COVID19 . In the meantime, health authorities caution against using it for the coronavirus.
New research implies that many social processes that drive spread of disease might be driving spread of songs. Music & infectious diseases depend on social connections to spread through populations.
Moderna Chief Executive Stéphane Bancel thinks the coronavirus pandemic could be over in a year as increased vaccine production ensures global supplies
Current Research in Microbial Sciences is a peer-reviewed gold open access research journal covering all aspects of the broad field of microbiology. It is a companion to the highly regarded review journal Current Opinion in Microbiology and part of Elsevier’s CO+RE suite of journals.